InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Foresite Capital Management IV, LLC. Officer active across 2 companies, notably Kinnate Biopharma Inc.. Aggregated, 4 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €3.9m. History available since 8 May 2023. The latest transaction was disclosed on 4 February 2026 (C). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Foresite Capital Management IV, LLC is a declarant with 4 filings in total. Among the sampled recent filings, purchases total EUR 3949274, sales total EUR 0, and the period runs from 2023-02-22 to 2026-02-06. The companies mentioned are Kinnate Biopharma Inc. and Eikon Therapeutics, Inc.